Woman's Lower Back Pain Reveals Hidden Artery Blockages and Rare Diagnosis
Woman's Lower Back Pain Reveals Hidden Artery Blockages and Rare Diagnosis
Woman's Lower Back Pain Reveals Hidden Artery Blockages and Rare Diagnosis
A young woman's persistent lower back pain has led to an unexpected medical discovery. Doctors initially suspected seronegative spondyloarthritis, a condition affecting the spine and joints. Further tests then revealed a surprising additional issue: significant blockages in her neck arteries.
The patient first sought help after months of worsening lower back pain. Unlike typical cases, her discomfort eased with movement and painkillers but flared up at rest. This pattern raised concerns about seronegative spondyloarthritis, a systemic inflammatory disease.
Diagnostic scans later uncovered atherosclerotic plaques narrowing nearly 50% of her neck blood vessels. The finding was unusual, as she lacked classic risk factors for atherosclerosis and reported no heart-related symptoms.
Alexander Subbotin, deputy director of the Institute of Clinical Medicine at Lobachevsky State University of Nizhny Novgorod, is overseeing her case. The patient remains under close observation and is currently receiving treatment for both conditions.
The case highlights the complexity of diagnosing overlapping conditions. Doctors continue to monitor her progress while addressing both the inflammatory disease and arterial blockages. Further updates will depend on her response to ongoing treatment.
Garlic, Vitamin C, and Chlorophyll Team Up for Heart Health Breakthrough
Could a simple blend of garlic, vitamin C, and chlorophyll be the key to a healthier heart? New findings reveal surprising benefits for blood pressure and beyond.
Chuck Norris, 86, hospitalized after medical emergency in Hawaii
From Walker, Texas Ranger to recent films, Norris never slowed down—until now. Fans worldwide await news after his sudden hospitalization.
Blood Test Breakthrough Could Detect Hidden Artery Disease Years Earlier
A simple blood test could soon reveal invisible plaque buildup—long before it triggers a deadly event. Machine learning cracked the code in 45,000 patients' data.
Eli Lilly's retatrutide shows groundbreaking results in Type 2 diabetes trial
A triple-hormone drug could redefine diabetes care. Early data shows retatrutide outperforms competitors—but will regulators agree?